Stockreport

CG Oncology (CGON) PT Raised to $79 by Morgan Stanley on Strong Clinical Pipeline for Bladder Cancer Treatment [Yahoo! Finance]

CG Oncology, Inc. - Common stock  (CGON) 
PDF price target on CG Oncology to $79 from $56, while maintaining an Overweight rating on the shares. Earlier in August, CG Oncology announced significant clinical advancem [Read more]